COMMUNIQUÉS West-GlobeNewswire

Auxly Congratulates Partner ICC International Cannabis Corp on Acquisition of Cannabis Genetics Company Green Gene Research Inc
20/11/2018
VANCOUVER, British Columbia, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V - XLY) (" Auxly " or the " Company ") is pleased to announce that its strategic international partner, ICC International [...]
Stryker to participate in Evercore ISI HealthCONx Conference
20/11/2018
Kalamazoo, Michigan, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the Evercore ISI HealthCONx Conference on Wednesday, November 28, 2018 at the Boston Harbor Hotel in Boston, Massachusetts. [...]
Capital Increase in Genmab as a Result of Employee Warrant Exercise
20/11/2018
Company Announcement Copenhagen, Denmark; November 20, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 7,588 shares as a consequence of the exercise of employee warrants. The increase is [...]
Santhera Calls Extraordinary General Meeting and Proposes Ordinary Share Capital Increase to Raise Approximately CHF 50 Million
20/11/2018
Pratteln, Switzerland, November 20, 2018 - Earlier today, Santhera Pharmaceuticals (SIX: SANN) announced that it has entered into an agreement to acquire the option for the exclusive sub-license to the first-in-class [...]
Santhera Enters into Agreement to Acquire Option from Idorsia for Exclusive Sub-License of First-in-class Dissociative Steroid Vamorolon
20/11/2018
Vamorolone in clinical development for Duchenne muscular dystrophy (DMD) by ReveraGen BioPharma Inc. - pivotal VISION-DMD Phase IIb study ongoing Vamorolone has the potential to become standard of care in young patients [...]
Santhera enters into agreement to acquire option from Idorsia for exclusive sub-license of first-in-class dissociative steroid vamorolone
20/11/2018
Vamorolone in clinical development for Duchenne muscular dystrophy (DMD) by ReveraGen BioPharma Inc. - pivotal VISION-DMD Phase 2b study ongoing Vamorolone has the potential to become standard of care in young patients [...]
Neovacs announces the patent filing in Europe and in the United States for its new therapeutic vaccine candidate Kinoid IL-4/IL-13 for the treatment of allergies
20/11/2018
PRESS RELEASE · PRESS RELEASE · PRESS RELEASE Neovacs announces the patent filing in Europe and in the United States for its new therapeutic vaccine candidate Kinoid IL-4/IL-13 for the treatment of allergies Paris and [...]
NÉOVACS : dépôt d'un brevet en Europe et aux États-Unis pour son nouveau candidat vaccin thérapeutique dans les allergies
20/11/2018
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Néovacs annonce le dépôt d'un brevet en Europe et aux États-Unis pour son nouveau candidat vaccin thérapeutique Kinoïde IL- 4/IL-13 dans le traitement [...]
Elite Pharmaceuticals Receives FDA Approval for Hydrocodone and Acetaminophen Combo
20/11/2018
NORTHVALE, N.J., Nov. 20, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP), a specialty pharmaceutical company developing abuse-deterrent opioids and niche generic products, [...]
NeuroMetrix Announces Issuance of New U.S. Patent for Quell Wearable Technology
20/11/2018
WALTHAM, Mass., Nov. 20, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,130,810 titled “Transcutaneous electrical nerve [...]
EDAP TMS SA : EDAP to Present a Corporate Update at the 30th Annual Piper Jaffray Conference
20/11/2018
LYON, France, November 20, 2018 - EDAP TMS SA (Nasdaq: EDAP), the global leader in therapeutic ultrasound, today announced that it will provide a corporate overview at the Piper Jaffray Conference, taking place November [...]
Auris Medical Announces Results of Pre-IND Meeting With FDA For AM-201 Program in Olanzapine-Induced Weight Gain
20/11/2018
Zug, Switzerland, November 20, 2018 - Auris Medical Holding AG (NASDAQ: EARS), a clinical-stage company dedicated to developing therapeutics that address important unmet medical needs in neurotology and mental health [...]
Shire plc: Phase I conditional clearance by the European Commission
20/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION FOR [...]
Data from Phase III MAIA Study of Daratumumab Accepted for Presentation at Annual Meeting of American Society of Hematology
20/11/2018
Media Release Data from Phase III MAIA study in front line multiple myeloma accepted as Late-breaking Abstract for oral presentation at ASH Annual Meeting Copenhagen, Denmark; November 20, 2018 – Genmab A/S (Nasdaq [...]
Aptevo Therapeutics to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Aptevo Therapeutics Inc. (Nasdaq: APVO), a biotechnology company focused on developing novel oncology and hematology therapeutics, today announced that management will be [...]
Alzamend Neuro™ Appoints New CEO, Bio-Pharma Executive Stephan Jackman
20/11/2018
Salt Lake City, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Alzamend Neuro™, Inc. (Alzamend™ or the “Company”) announced today that it has appointed bio-pharma executive, Mr. Stephan Jackman, as its new Chief Executive Officer in [...]
Pure Global Poised to Advance Its Innovative Products to Distribution Channels -- CFN Media
20/11/2018
SEATTLE, Nov. 20, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Zenith Epigenetics Announces Clinical Trial Collaboration with Pfizer
20/11/2018
Collaboration to evaluate ZEN-3694 in combination with Talazoparib in TNBC patients; Phase 1b/2 trial expected to initiate 1Q 2019 CALGARY, Alberta, Nov. 20, 2018 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or [...]
ChemoCentryx to Present at the 30th Annual Piper Jaffray Healthcare Conference
20/11/2018
MOUNTAIN VIEW, Calif., Nov. 20, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 30th Annual Piper [...]

Pages